US FDA approves Kaneka's Lixelle Column to treat dialysis-related amyloidosis ... - pharmabiz.com PDF Print
pharmabiz.com
“While DRA affects only a small population of patients on dialysis, there are not many treatment options for these patients and some options may not be available to patients in all areas,” says William Maisel, MD, M.P.H., deputy director for science

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.